Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome

NCT05397392 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2022-06-02

No results posted yet for this study

Summary

To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes

Conditions

Interventions

OTHER

guideline recommended routine treatment

Sponsors & Collaborators

  • Nanjing First Hospital, Nanjing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05397392 on ClinicalTrials.gov